Atlas Trials

Analysis of Patients Treated With Bevacizumab Intraperitoneal for the Treatment of Refractory Malignant Ascites

Clinical trial NCT02891369 · COMPLETED

Trial details

NCT number
NCT02891369
Sponsor
Fondation Hôpital Saint-Joseph
Status
COMPLETED
Study type
OBSERVATIONAL
Refractory Malignant Ascites
Start date
2015-02-01
Primary completion
2015-05-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.